[New insight into DNA methylation in CML and its effect on clinical outcome--review]

Yong Tang1, Jun-Pei Hu

  • 1Department of Hematology, The Ninth People Hospital, Shanghai Jiaotong University Medical College, Shanghai 200011, China.

Insights

DNA methylation patterns are specific to tumors. This review covers DNA methylation changes in chronic myeloid leukemia (CML), including gene hypomethylation and hypermethylation, and their role in CML progression and prognosis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Epigenetics

Context:

  • Tumorigenesis is characterized by specific DNA methylation patterns.
  • Chronic myeloid leukemia (CML) exhibits distinct epigenetic alterations.
  • Understanding these changes is crucial for CML research.

Purpose:

  • To review DNA methylation alterations in chronic myeloid leukemia (CML).
  • To explore the role of DNA methylation in CML's clinical stages.
  • To assess the utility of DNA methylation in CML prognosis evaluation.

Summary:

  • DNA methylation changes in CML involve hypomethylation of oncogenes and hypermethylation of tumor-suppressor and fusion genes.
  • These epigenetic modifications are linked to disease progression.
  • The study examines the relationship between DNA methylation and CML.

Impact:

  • Provides insights into the epigenetic landscape of CML.
  • Highlights the potential of DNA methylation as a biomarker for CML staging and prognosis.
  • Contributes to a deeper understanding of CML pathogenesis.